Koers Urologix, Inc. Other OTC
Aandelen
ULGX
US9172731047
Geavanceerde medische apparatuur & technologie
Omzet 2013 | 16,48 mln. 15,2 mln. | Omzet 2014 | 14,01 mln. 12,92 mln. | Marktkapitalisatie | 3,66 mln. 3,38 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2013 | -4 mln. -3,69 mln. | Nettowinst (verlies) 2014 | -7 mln. -6,45 mln. | EV/omzet 2013 | 0,4 x |
Nettoschuld 2013 | 3,04 mln. 2,81 mln. | Nettoschuld 2014 | 4,62 mln. 4,25 mln. | EV/omzet 2014 | 0,59 x |
K/w-verhouding 2013 |
-0,8
x | K/w-verhouding 2014 |
-0,49
x | Werknemers | - |
Dividendrendement 2013 * |
-
| Dividendrendement 2014 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Mitchell Dann
FOU | Founder | 63 | 29-05-91 |
Scott Madson
DFI | Director of Finance/CFO | 63 | 01-04-15 |
Lisa Ackermann
SAM | Sales & Marketing | 51 | 16-06-11 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Mitchell Dann
FOU | Founder | 63 | 29-05-91 |
Sidney Emery
BRD | Director/Board Member | 74 | 01-10-05 |
Director/Board Member | 57 | 06-08-10 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+9,74% | 223 mld. | |
+13,21% | 194 mld. | |
+19,30% | 141 mld. | |
+31,33% | 109 mld. | |
+1,71% | 64,85 mld. | |
+15,10% | 52,7 mld. | |
+6,68% | 51,77 mld. | |
+7,83% | 44,12 mld. | |
+2,85% | 36,21 mld. |